FDA
Metaraminol Bitartrate
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- METARAMINOL BITARTRATE EQ 10MG BASE/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METARAMINOL BITARTRATE EQ 10MG BASE/ML · InjectableANDA080431-001 · Discontinued
- METARAMINOL BITARTRATE EQ 10MG BASE/ML · InjectableANDA080722-001 · Discontinued
- METARAMINOL BITARTRATE EQ 10MG BASE/ML · InjectableANDA083363-001 · Discontinued
- METARAMINOL BITARTRATE EQ 10MG BASE/ML · InjectableANDA086418-001 · Discontinued
- METARAMINOL BITARTRATE EQ 20MG BASE/ML · InjectableANDA086418-002 · Discontinued
- METARAMINOL BITARTRATE EQ 10MG BASE/ML · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA211304.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Metaraminol Bitartrate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Azurity
- Status
- Prescription
- FDA approval
- 24 Aug 2021
- Application
- ANDA211304-001